Table 8 Comparison of each peptide level between subjects with and those without metabolic syndrome

From: Associations of cardiovascular risk with circulating peptides related to hypertensive disorders of pregnancy

 

Without MetS (univariable)

With MetS (univariable)

Without MetS (multivariable)

With MetS (multivariable)

Log (P-2081)

−0.830 ± 0.026

−0.886 ± 0.033

−0.836 ± 0.025

−0.870 ± 0.042

Log (P-2091)

1.554 ± 0.022

1.485 ± 0.035

1.550 ± 0.022

1.496 ± 0.037

Log (P-2127)

−1.267 ± 0.020

−1.208 ± 0.074

−1.279 ± 0.029

−1.176 ± 0.049

Log (P-2209)

−0.483 ± 0.014

−0.488 ± 0.029

−0.486 ± 0.016

−0.482 ± 0.026

Log (P-2378)

2.034 ± 0.015

2.010 ± 0.027

2.032 ± 0.016

2.015 ± 0.026

Log (P-2858)

3.500 ± 0.012

3.521 ± 0.018

3.499 ± 0.012

3.523 ± 0.021

Log (P-3156)

0.594 ± 0.022

0.541 ± 0.031

0.594 ± 0.021

0.540 ± 0.036

  1. Shown are means with standard errors of each peptide level (ng/ml) after logarithmic transformation. MetS metabolic syndrome. In multivariable analysis, age and histories of smoking and alcohol drinking were used as covariates for adjustment